OTC analgesics in headache treatment: Open-label phase vs randomized double-blind phase of a large clinical trial

Headache

Volumn 49, Issue 5, 2009, Pages 638-645

  Pfaffenrath, Volker ^a   Diener, Hans Christoph ^b   Pageler, Lutz ^c   Peil, Hubertus ^d   Aicher, Bernhard ^d  

^a Neurologe   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Clinical trial; Headache; Open label phase; OTC analgesics; Randomized double blind phase; Thomapyrin Study

Indexed keywords

ACETYLSALICYLIC ACID; CAFFEINE; EXCEDRIN; IBUPROFEN; PARACETAMOL; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; HEADACHE; HUMAN; MIGRAINE; PAIN ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VISUAL ANALOG SCALE;

ACETAMINOPHEN; ADOLESCENT; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ASPIRIN; CAFFEINE; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PAIN MEASUREMENT; PHOSPHODIESTERASE INHIBITORS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65449139154     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01402.x     Document Type: Article

References (15)

1. Jensen R, Symon D. Epidemiology of tension-type headaches. In : Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, eds. The Headaches, 3rd edn, Chapter 67. Philadelphia, PA : Lippincott Williams & Wilkins 2006 : 621 624.
2. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States - Epidemiology and patterns of health care use. Neurology. 2002 58 : 885 894. (Pubitemid 34242063)
3. Haag G, Evers S, May A, Neu IS, Vivell W, Ziegler A. Selbstmedikation bei Migräne und Kopfschmerz vom Spannungstyp - Evidenz-basierte Empfehlungen der Deutschen Migräne und Kopfschmerzgesellschaft (DMKG). [Self-medication in migraine and tension-type headache - Evidence-based treatment recommendations of the German Migraine and Headache Society.] Nervenheilkunde. 2004 23 : 415 430.
4. Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B, Lipton RB. Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesics. Cephalalgia. 2008 29 : 188 193.
5. Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: A multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia. 2005 25 : 776 787. (Pubitemid 41368672)
6. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1998 8 (Suppl. 7 1 96.
7. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. Boston, MA : John Wright PSG Inc 1982 : 1 224.
8. Schachtel BP, Thoden WR. Onset of action in the treatment of muscle-contraction headache. Headache. 1988 28 : 471 474.
9. Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT. Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther. 1994 56 : 576 586. (Pubitemid 24370365)
10. Packman B, Packman E, Doyle G, et al. Solubilized ibuprofen: Evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache. 2000 40 : 561 567. (Pubitemid 30497414)
11. Committee for Proprietary Medical Products (CPMP). Note for guidance on clinical investigation of medicinal products for treatment of pain. CPMP/EWP/612/00, 2001 : 1 14.
12. Pageler L, Diener HC, Pfaffenrath V, Peil H, Aicher B. Clinical relevance of efficacy endpoints in OTC headache trials. Headache. 2008. doi: 10.1111/j.1526-4610.2008.01242.x.
13. Branthwaite A, Cooper P. Analgesic effects of branding in treatment of headaches. BMJ. 1981 282 : 1576 1578. (Pubitemid 11098211)
14. Pascual J, Diener HC, Massiou H. Value of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: Using almotriptan as an example. J Headache Pain. 2006 7 : 27 33. (Pubitemid 43337098)
15. Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet. 2002 359 : 248 252. (Pubitemid 34113828)